Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2023-10-01
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dextrose Effect on Postoperative Nausea and Vomiting (PONV)
NCT04726436
Preoperative Dextrose Infusion and Postoperative Nausea and Vomiting
NCT06288542
Effect of Intravenous Dextrose on PONV in Patients Undergoing Gynecological Laparoscopy
NCT05932160
Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery
NCT03139383
Dexmedetomidine for Prophylaxis Against PONV in Highly Susceptible Patients.
NCT05134363
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Patients will be fasted and not receiving any pre-operative fluids
No interventions assigned to this group
Dextrose group
Patients will take 100ml/HR of clear fluids (apple juice) during the fasting hours till 2 hrs before the operation and will receive dextrose 5% infusion at a rate of 1ml/kg/h 2hrs before the operation and till the end of the operation
Dextrose 5%, normal saline
Decrease fasting hours
Normal saline group
Patients will take 100ml/HR of water during the fasting hours till 2 hrs before the operation and will receive normal saline 0.9% at a rate of 1ml/kg/h (group NS) intravenously (IV)2hrs before the operation and till the end of the operation
Dextrose 5%, normal saline
Decrease fasting hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dextrose 5%, normal saline
Decrease fasting hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing middle ear surgeries, mastoidectomy, or tympanoplasty
Exclusion Criteria
* history of motion sickness
* presence of psychiatric illness
* pregnant and lactating women
* cardiovascular disorders (Ischemic heart diseases, congestive heart failure and valvular diseases)
* Diabetic patients
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shymaa Fathy
Assistant professor of anesthesia and SICU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine- Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS-206-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.